Skip to main content
Công ty Cổ phần Dược phẩm Imexpharm logo

Công ty Cổ phần Dược phẩm Imexpharm — Investor Relations & Filings

Ticker · IMP ISIN · VN000000IMP0 HSX Manufacturing
Open in API
Filings indexed 278 across all filing types
Latest filing 2026-05-11 Director's Dealing
Country VN Viet Nam
Listing HSX IMP

About Công ty Cổ phần Dược phẩm Imexpharm

www.imexpharm.com

Imexpharm Corporation is a prominent pharmaceutical company with over 48 years of experience in the manufacturing, compounding, and distribution of high-quality pharmaceutical products. The company operates extensive production facilities, including three EU-GMP certified factory clusters and one WHO-GMP certified cluster, making it a leader in EU-GMP compliant manufacturing. Imexpharm is recognized as a top producer of antibiotics and offers a diverse product portfolio encompassing injectable and oral antibiotics, cardiovascular, ophthalmic, musculoskeletal, respiratory, and digestive system treatments, alongside vitamins, minerals, and health protection foods. With 28 product registrations for 11 products in Europe, Imexpharm is dedicated to delivering effective and safe healthcare solutions to the community.

Recent filings

Filing Released Lang Actions
IMP: Báo cáo kết quả giao dịch cổ phiếu của Người nội bộ Trần Thị Đào, Huỳnh Văn Nhung, Dương Hoàng Vũ, Ngô Minh Tuấn
Director's Dealing Classification · 92% confidence The document is a formal report detailing the share transactions (selling 371,400 shares) conducted by an insider (Trần Thị Đào) of Imexpharm Corporation, including pre- and post-transaction holdings, transaction value, method, and date. This matches the definition of “Director’s Dealing” (insider personal share transactions) rather than a company buyback or other regulatory filing. Therefore, it should be classified under DIRS.
2026-05-11 Vietnamese
IMP: Báo cáo về ngày trở thành cổ đông lớn Lian SGP Holding Pte. Ltd.
Major Shareholding Notification Classification · 95% confidence The document is a formal notification to the State Securities Commission, the Hochiminh Stock Exchange, and the listed company that LIAN SGP HOLDING PTE. LTD. has become a major shareholder by acquiring more than 5% of the company’s shares. It details share counts before and after the purchase, ownership percentages, the trading date, and related party holdings. This matches the definition of a Major Shareholding Notification (crossing the 5% threshold).
2026-05-11 Vietnamese
IMP: Giấy chứng nhận đăng ký doanh nghiệp thay đổi lần thứ 35
Regulatory Filings Classification · 85% confidence The document is a formal disclosure filed on the State Securities Commission and Ho Chi Minh Stock Exchange portals announcing changes to the company’s enterprise registration certificate — specifically updates to its business codes, descriptions, and registered address. It does not present financial statements, earnings, management discussion, or dividend details, nor is it an announcement of a report’s publication. It is a general regulatory compliance notice, fitting the fallback category “Regulatory Filings.”
2026-05-07 Vietnamese
IMP: Báo cáo kết quả giao dịch cổ phiếu của tổ chức có liên quan đến Người nội bộ Công ty Cổ phần Đầu tư Bình Minh Kim
Director's Dealing Classification · 95% confidence The document is a formal report on the results of share transactions by an internal person and affiliated parties, addressed to the State Securities Commission and the stock exchange. It details insider trades (sale and transfer of shares by a director), including quantities, dates, and parties involved. This matches the definition of a Director’s Dealing report.
2026-04-29 Vietnamese
IMP: Báo cáo kết quả giao dịch cổ phiếu của tổ chức có liên quan đến Người nội bộ Công ty Cổ phần Đầu tư KBA, SK Investment Vina III Pte. Ltd.
Director's Dealing Classification · 98% confidence The document is a regulatory report submitted to the securities commission and stock exchange detailing share transactions by an insider (an internal person and affiliated person), including amounts held before and after, transaction dates, and purpose. This matches the definition of an insider or director’s dealing report. Therefore, it should be classified as Director’s Dealing (DIRS).
2026-04-29 Vietnamese
IMP: Báo cáo kết quả đợt chào mua công khai cổ phiếu IMP của Lian SGP Holding Pte. Ltd.
M&A Activity Classification · 90% confidence The document is a detailed report on the public tender offer (takeover bid) by LIAN SGP HOLDING PTE. LTD. for shares of Imexpharm Corporation, including purchase results, share counts, percentages, offer price, financing, and dates. This clearly falls under M&A Activity (takeover bid) rather than financial results, management changes, or regulatory filings. Therefore, the correct classification is M&A Activity (Code: TAR).
2026-04-28 Vietnamese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.